Skip to content

Author

Hui Xu

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

End-of-season influenza vaccine effectiveness against a(H3N2) and B/Victoria in Beijing, China, 2025/26 season.

INTRODUCTION This study aimed to estimate the end-of-season influenza vaccine effectiveness (VE) against A(H3N2) and B/Victoria in the 2025/26 season in Beijing, China. METHODS We used a test-negative design to assess influenza VE among outpatients with influenza-like illness (ILI) enrolled through the Beijing influe...

Jiao-Jiao Zhang, Ying Shen, Wei-Xian Shi et al. · 0 citations
Open access Sep 2026

The E3 ubiquitin ligase IDOL suppresses PRRSV replication by targeting viral Nsp3 for SQSTM1-mediated selective autophagic degradation

An autophagy-dependent antiviral mechanism is uncovered, IDOL is established as an innate immune regulator with a non-canonical function, and a viral immune evasion strategy is defined, positioning IDOL as a promising therapeutic target for PRRSV control.

Jie-Cong Yan, Yu-Han Wu, Hui Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.